Form 4 for ADIL ADIAL PHARMACEUTICALS, INC.
Accepted 2021-12-23 00:00:00 ET · period of report 2021-12-23 · accession 0001213900-21-067352 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-23 | 2021-12-23 | ADIL | Schuyler Kevin | Dir, 10% | G - Gift | $0.00 | -313.0K | 0 | -100% | $0 |
| D | 2021-12-23 | 2021-12-23 | ADIL | Schuyler Kevin | Dir, 10% | G - Gift | $0.00 | -90.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-23 | G | D | 312,990 | $0.00 | 0 | D | — | — | |
| 2 | Derivative | Warrant to purchase common stock | 2021-12-23 | G | D | 90,000 | $0.00 | 0 | D | $6.25 · 2018-07-31 to 2023-07-31 | 90,000 Common Stock |